 | • レポートコード：GIR-2104Z07253 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ヒト凝固因子Ⅷのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ヒト凝固因子Ⅷの種類別市場規模（リコンビナント第VIII因子、ヒューマン第VIII因子）、用途別市場規模（血友病A、出血性出血性疾患）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ヒト凝固因子Ⅷの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Bayer、CSL Behring、Baxter、Grifols、Octapharma、Pfizer、Taibang Bio、Shanghai Laishi、Hualan Bio、Guangdong Shuanglin、GreenCross ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：リコンビナント第VIII因子、ヒューマン第VIII因子 ・用途別分析2016年-2026年：血友病A、出血性出血性疾患 ・ヒト凝固因子Ⅷの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ヒト凝固因子Ⅷのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ヒト凝固因子Ⅷのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ヒト凝固因子Ⅷの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ヒト凝固因子Ⅷの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Human Coagulation Factor Ⅷ market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Human Coagulation Factor Ⅷ size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Human Coagulation Factor Ⅷ market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Human Coagulation Factor Ⅷ market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Recombinant Factor VIII
Human Factor VIII
Market segment by Application can be divided into
Hemophilia A
Relvent Bleeding Diseases
The key market players for global Human Coagulation Factor Ⅷ market are listed below:
Bayer
CSL Behring
Baxter
Grifols
Octapharma
Pfizer
Taibang Bio
Shanghai Laishi
Hualan Bio
Guangdong Shuanglin
GreenCross
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Human Coagulation Factor Ⅷ Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Coagulation Factor Ⅷ Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Recombinant Factor VIII
1.2.3 Human Factor VIII
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Coagulation Factor Ⅷ Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hemophilia A
1.3.3 Relvent Bleeding Diseases
1.4 Global Human Coagulation Factor Ⅷ Market Size & Forecast
1.4.1 Global Human Coagulation Factor Ⅷ Sales in Value (2016-2026))
1.4.2 Global Human Coagulation Factor Ⅷ Sales in Volume (2016-2026)
1.4.3 Global Human Coagulation Factor Ⅷ Price by Type (2016-2026) & (US$/Unit)
1.5 Global Human Coagulation Factor Ⅷ Production Capacity Analysis
1.5.1 Global Human Coagulation Factor Ⅷ Total Production Capacity (2016-2026)
1.5.2 Global Human Coagulation Factor Ⅷ Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Human Coagulation Factor Ⅷ Market Drivers
1.6.2 Human Coagulation Factor Ⅷ Market Restraints
1.6.3 Human Coagulation Factor Ⅷ Trends Analysis
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer Human Coagulation Factor Ⅷ Product and Services
2.1.4 Bayer Human Coagulation Factor Ⅷ Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 CSL Behring
2.2.1 CSL Behring Details
2.2.2 CSL Behring Major Business
2.2.3 CSL Behring Human Coagulation Factor Ⅷ Product and Services
2.2.4 CSL Behring Human Coagulation Factor Ⅷ Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Baxter
2.3.1 Baxter Details
2.3.2 Baxter Major Business
2.3.3 Baxter Human Coagulation Factor Ⅷ Product and Services
2.3.4 Baxter Human Coagulation Factor Ⅷ Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Grifols
2.4.1 Grifols Details
2.4.2 Grifols Major Business
2.4.3 Grifols Human Coagulation Factor Ⅷ Product and Services
2.4.4 Grifols Human Coagulation Factor Ⅷ Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Octapharma
2.5.1 Octapharma Details
2.5.2 Octapharma Major Business
2.5.3 Octapharma Human Coagulation Factor Ⅷ Product and Services
2.5.4 Octapharma Human Coagulation Factor Ⅷ Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Human Coagulation Factor Ⅷ Product and Services
2.6.4 Pfizer Human Coagulation Factor Ⅷ Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Taibang Bio
2.7.1 Taibang Bio Details
2.7.2 Taibang Bio Major Business
2.7.3 Taibang Bio Human Coagulation Factor Ⅷ Product and Services
2.7.4 Taibang Bio Human Coagulation Factor Ⅷ Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Shanghai Laishi
2.8.1 Shanghai Laishi Details
2.8.2 Shanghai Laishi Major Business
2.8.3 Shanghai Laishi Human Coagulation Factor Ⅷ Product and Services
2.8.4 Shanghai Laishi Human Coagulation Factor Ⅷ Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Hualan Bio
2.9.1 Hualan Bio Details
2.9.2 Hualan Bio Major Business
2.9.3 Hualan Bio Human Coagulation Factor Ⅷ Product and Services
2.9.4 Hualan Bio Human Coagulation Factor Ⅷ Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Guangdong Shuanglin
2.10.1 Guangdong Shuanglin Details
2.10.2 Guangdong Shuanglin Major Business
2.10.3 Guangdong Shuanglin Human Coagulation Factor Ⅷ Product and Services
2.10.4 Guangdong Shuanglin Human Coagulation Factor Ⅷ Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 GreenCross
2.11.1 GreenCross Details
2.11.2 GreenCross Major Business
2.11.3 GreenCross Human Coagulation Factor Ⅷ Product and Services
2.11.4 GreenCross Human Coagulation Factor Ⅷ Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Human Coagulation Factor Ⅷ Sales by Manufacturer
3.1 Global Human Coagulation Factor Ⅷ Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Human Coagulation Factor Ⅷ Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Human Coagulation Factor Ⅷ
3.4 Market Concentration Rate
3.4.1 Top 3 Human Coagulation Factor Ⅷ Manufacturer Market Share
3.4.2 Top 6 Human Coagulation Factor Ⅷ Manufacturer Market Share
3.5 Global Human Coagulation Factor Ⅷ Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Human Coagulation Factor Ⅷ Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Human Coagulation Factor Ⅷ Market Size by Region
4.1.1 Global Human Coagulation Factor Ⅷ Sales in Volume by Region (2016-2026)
4.1.2 Global Human Coagulation Factor Ⅷ Revenue by Region (2016-2026)
4.2 North America Human Coagulation Factor Ⅷ Revenue (2016-2026)
4.3 Europe Human Coagulation Factor Ⅷ Revenue (2016-2026)
4.4 Asia-Pacific Human Coagulation Factor Ⅷ Revenue (2016-2026)
4.5 South America Human Coagulation Factor Ⅷ Revenue (2016-2026)
4.6 Middle East and Africa Human Coagulation Factor Ⅷ Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Human Coagulation Factor Ⅷ Sales in Volume by Type (2016-2026)
5.2 Global Human Coagulation Factor Ⅷ Revenue by Type (2016-2026)
5.3 Global Human Coagulation Factor Ⅷ Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Human Coagulation Factor Ⅷ Sales in Volume by Application (2016-2026)
6.2 Global Human Coagulation Factor Ⅷ Revenue by Application (2016-2026)
6.3 Global Human Coagulation Factor Ⅷ Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Human Coagulation Factor Ⅷ Sales by Type (2016-2026)
7.2 North America Human Coagulation Factor Ⅷ Sales by Application (2016-2026)
7.3 North America Human Coagulation Factor Ⅷ Market Size by Country
7.3.1 North America Human Coagulation Factor Ⅷ Sales in Volume by Country (2016-2026)
7.3.2 North America Human Coagulation Factor Ⅷ Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Human Coagulation Factor Ⅷ Sales by Type (2016-2026)
8.2 Europe Human Coagulation Factor Ⅷ Sales by Application (2016-2026)
8.3 Europe Human Coagulation Factor Ⅷ Market Size by Country
8.3.1 Europe Human Coagulation Factor Ⅷ Sales in Volume by Country (2016-2026)
8.3.2 Europe Human Coagulation Factor Ⅷ Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Human Coagulation Factor Ⅷ Sales by Type (2016-2026)
9.2 Asia-Pacific Human Coagulation Factor Ⅷ Sales by Application (2016-2026)
9.3 Asia-Pacific Human Coagulation Factor Ⅷ Market Size by Region
9.3.1 Asia-Pacific Human Coagulation Factor Ⅷ Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Human Coagulation Factor Ⅷ Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Human Coagulation Factor Ⅷ Sales by Type (2016-2026)
10.2 South America Human Coagulation Factor Ⅷ Sales by Application (2016-2026)
10.3 South America Human Coagulation Factor Ⅷ Market Size by Country
10.3.1 South America Human Coagulation Factor Ⅷ Sales in Volume by Country (2016-2026)
10.3.2 South America Human Coagulation Factor Ⅷ Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Human Coagulation Factor Ⅷ Sales by Type (2016-2026)
11.2 Middle East & Africa Human Coagulation Factor Ⅷ Sales by Application (2016-2026)
11.3 Middle East & Africa Human Coagulation Factor Ⅷ Market Size by Country
11.3.1 Middle East & Africa Human Coagulation Factor Ⅷ Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Human Coagulation Factor Ⅷ Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Human Coagulation Factor Ⅷ Typical Distributors
12.3 Human Coagulation Factor Ⅷ Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Human Coagulation Factor Ⅷ Revenue by Type, (USD Million), 2021-2026
Table 2. Global Human Coagulation Factor Ⅷ Revenue by Application, (USD Million), 2021-2026
Table 3. Bayer Basic Information, Manufacturing Base and Competitors
Table 4. Bayer Major Business
Table 5. Bayer Human Coagulation Factor Ⅷ Product and Services
Table 6. Bayer Human Coagulation Factor Ⅷ Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 8. CSL Behring Major Business
Table 9. CSL Behring Human Coagulation Factor Ⅷ Product and Services
Table 10. CSL Behring Human Coagulation Factor Ⅷ Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Baxter Basic Information, Manufacturing Base and Competitors
Table 12. Baxter Major Business
Table 13. Baxter Human Coagulation Factor Ⅷ Product and Services
Table 14. Baxter Human Coagulation Factor Ⅷ Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Grifols Basic Information, Manufacturing Base and Competitors
Table 16. Grifols Major Business
Table 17. Grifols Human Coagulation Factor Ⅷ Product and Services
Table 18. Grifols Human Coagulation Factor Ⅷ Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Octapharma Basic Information, Manufacturing Base and Competitors
Table 20. Octapharma Major Business
Table 21. Octapharma Human Coagulation Factor Ⅷ Product and Services
Table 22. Octapharma Human Coagulation Factor Ⅷ Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Pfizer Basic Information, Manufacturing Base and Competitors
Table 24. Pfizer Major Business
Table 25. Pfizer Human Coagulation Factor Ⅷ Product and Services
Table 26. Pfizer Human Coagulation Factor Ⅷ Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Taibang Bio Basic Information, Manufacturing Base and Competitors
Table 28. Taibang Bio Major Business
Table 29. Taibang Bio Human Coagulation Factor Ⅷ Product and Services
Table 30. Taibang Bio Human Coagulation Factor Ⅷ Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Shanghai Laishi Basic Information, Manufacturing Base and Competitors
Table 32. Shanghai Laishi Major Business
Table 33. Shanghai Laishi Human Coagulation Factor Ⅷ Product and Services
Table 34. Shanghai Laishi Human Coagulation Factor Ⅷ Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 36. Hualan Bio Major Business
Table 37. Hualan Bio Human Coagulation Factor Ⅷ Product and Services
Table 38. Hualan Bio Human Coagulation Factor Ⅷ Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Guangdong Shuanglin Basic Information, Manufacturing Base and Competitors
Table 40. Guangdong Shuanglin Major Business
Table 41. Guangdong Shuanglin Human Coagulation Factor Ⅷ Product and Services
Table 42. Guangdong Shuanglin Human Coagulation Factor Ⅷ Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. GreenCross Basic Information, Manufacturing Base and Competitors
Table 44. GreenCross Major Business
Table 45. GreenCross Human Coagulation Factor Ⅷ Product and Services
Table 46. GreenCross Human Coagulation Factor Ⅷ Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Global Human Coagulation Factor Ⅷ Sales by Manufacturer (2019-2021e) & (K Units)
Table 48. Global Human Coagulation Factor Ⅷ Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 49. Market Position of Manufacturers in Human Coagulation Factor Ⅷ, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 50. Global Human Coagulation Factor Ⅷ Production Capacity by Company, (K Units): 2020 VS 2021
Table 51. Head Office and Human Coagulation Factor Ⅷ Production Site of Key Manufacturer
Table 52. Global Human Coagulation Factor Ⅷ Sales by Region (2016-2021e) & (K Units)
Table 53. Global Human Coagulation Factor Ⅷ Sales by Region (2021-2026) & (K Units)
Table 54. Global Human Coagulation Factor Ⅷ Revenue by Region (2016-2021e) & (USD Million)
Table 55. Global Human Coagulation Factor Ⅷ Revenue by Region (2021-2026) & (USD Million)
Table 56. Global Human Coagulation Factor Ⅷ Sales by Type (2016-2021e) & (K Units)
Table 57. Global Human Coagulation Factor Ⅷ Sales by Type (2021-2026) & (K Units)
Table 58. Global Human Coagulation Factor Ⅷ Revenue by Type (2016-2021e) & (USD Million)
Table 59. Global Human Coagulation Factor Ⅷ Revenue by Type (2021-2026) & (USD Million)
Table 60. Global Human Coagulation Factor Ⅷ Price by Type (2016-2021e) & (US$/Unit)
Table 61. Global Human Coagulation Factor Ⅷ Price by Type (2021-2026) & (US$/Unit)
Table 62. Global Human Coagulation Factor Ⅷ Sales by Application (2016-2021e) & (K Units)
Table 63. Global Human Coagulation Factor Ⅷ Sales by Application (2021-2026) & (K Units)
Table 64. Global Human Coagulation Factor Ⅷ Revenue by Application (2016-2021e) & (USD Million)
Table 65. Global Human Coagulation Factor Ⅷ Revenue by Application (2021-2026) & (USD Million)
Table 66. Global Human Coagulation Factor Ⅷ Price by Application (2016-2021e) & (US$/Unit)
Table 67. Global Human Coagulation Factor Ⅷ Price by Application (2021-2026) & (US$/Unit)
Table 68. North America Human Coagulation Factor Ⅷ Sales by Country (2016-2021e) & (K Units)
Table 69. North America Human Coagulation Factor Ⅷ Sales by Country (2021-2026) & (K Units)
Table 70. North America Human Coagulation Factor Ⅷ Revenue by Country (2016-2021e) & (USD Million)
Table 71. North America Human Coagulation Factor Ⅷ Revenue by Country (2021-2026) & (USD Million)
Table 72. North America Human Coagulation Factor Ⅷ Sales by Type (2016-2021e) & (K Units)
Table 73. North America Human Coagulation Factor Ⅷ Sales by Type (2021-2026) & (K Units)
Table 74. North America Human Coagulation Factor Ⅷ Sales by Application (2016-2021e) & (K Units)
Table 75. North America Human Coagulation Factor Ⅷ Sales by Application (2021-2026) & (K Units)
Table 76. Europe Human Coagulation Factor Ⅷ Sales by Country (2016-2021e) & (K Units)
Table 77. Europe Human Coagulation Factor Ⅷ Sales by Country (2021-2026) & (K Units)
Table 78. Europe Human Coagulation Factor Ⅷ Revenue by Country (2016-2021e) & (USD Million)
Table 79. Europe Human Coagulation Factor Ⅷ Revenue by Country (2021-2026) & (USD Million)
Table 80. Europe Human Coagulation Factor Ⅷ Sales by Type (2016-2021e) & (K Units)
Table 81. Europe Human Coagulation Factor Ⅷ Sales by Type (2021-2026) & (K Units)
Table 82. Europe Human Coagulation Factor Ⅷ Sales by Application (2016-2021e) & (K Units)
Table 83. Europe Human Coagulation Factor Ⅷ Sales by Application (2021-2026) & (K Units)
Table 84. Asia-Pacific Human Coagulation Factor Ⅷ Sales by Region (2016-2021e) & (K Units)
Table 85. Asia-Pacific Human Coagulation Factor Ⅷ Sales by Region (2021-2026) & (K Units)
Table 86. Asia-Pacific Human Coagulation Factor Ⅷ Revenue by Region (2016-2021e) & (USD Million)
Table 87. Asia-Pacific Human Coagulation Factor Ⅷ Revenue by Region (2021-2026) & (USD Million)
Table 88. Asia-Pacific Human Coagulation Factor Ⅷ Sales by Type (2016-2021e) & (K Units)
Table 89. Asia-Pacific Human Coagulation Factor Ⅷ Sales by Type (2021-2026) & (K Units)
Table 90. Asia-Pacific Human Coagulation Factor Ⅷ Sales by Application (2016-2021e) & (K Units)
Table 91. Asia-Pacific Human Coagulation Factor Ⅷ Sales by Application (2021-2026) & (K Units)
Table 92. South America Human Coagulation Factor Ⅷ Sales by Country (2016-2021e) & (K Units)
Table 93. South America Human Coagulation Factor Ⅷ Sales by Country (2021-2026) & (K Units)
Table 94. South America Human Coagulation Factor Ⅷ Revenue by Country (2016-2021e) & (USD Million)
Table 95. South America Human Coagulation Factor Ⅷ Revenue by Country (2021-2026) & (USD Million)
Table 96. South America Human Coagulation Factor Ⅷ Sales by Type (2016-2021e) & (K Units)
Table 97. South America Human Coagulation Factor Ⅷ Sales by Type (2021-2026) & (K Units)
Table 98. South America Human Coagulation Factor Ⅷ Sales by Application (2016-2021e) & (K Units)
Table 99. South America Human Coagulation Factor Ⅷ Sales by Application (2021-2026) & (K Units)
Table 100. Middle East & Africa Human Coagulation Factor Ⅷ Sales by Country (2016-2021e) & (K Units)
Table 101. Middle East & Africa Human Coagulation Factor Ⅷ Sales by Country (2021-2026) & (K Units)
Table 102. Middle East & Africa Human Coagulation Factor Ⅷ Revenue by Country (2016-2021e) & (USD Million)
Table 103. Middle East & Africa Human Coagulation Factor Ⅷ Revenue by Country (2021-2026) & (USD Million)
Table 104. Middle East & Africa Human Coagulation Factor Ⅷ Sales by Type (2016-2021e) & (K Units)
Table 105. Middle East & Africa Human Coagulation Factor Ⅷ Sales by Type (2021-2026) & (K Units)
Table 106. Middle East & Africa Human Coagulation Factor Ⅷ Sales by Application (2016-2021e) & (K Units)
Table 107. Middle East & Africa Human Coagulation Factor Ⅷ Sales by Application (2021-2026) & (K Units)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Human Coagulation Factor Ⅷ Typical Distributors
Table 111. Human Coagulation Factor Ⅷ Typical Customers
List of Figures
Figure 1. Human Coagulation Factor Ⅷ Picture
Figure 2. Global Human Coagulation Factor Ⅷ Sales Market Share by Type in 2020
Figure 3. Recombinant Factor VIII
Figure 4. Human Factor VIII
Figure 5. Global Human Coagulation Factor Ⅷ Sales Market Share by Application in 2020
Figure 6. Hemophilia A
Figure 7. Relvent Bleeding Diseases
Figure 8. Global Human Coagulation Factor Ⅷ Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 9. Global Human Coagulation Factor Ⅷ Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. United States Human Coagulation Factor Ⅷ Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 11. Canada Human Coagulation Factor Ⅷ Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Mexico Human Coagulation Factor Ⅷ Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Germany Human Coagulation Factor Ⅷ Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. France Human Coagulation Factor Ⅷ Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. United Kingdom Human Coagulation Factor Ⅷ Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Russia Human Coagulation Factor Ⅷ Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Italy Human Coagulation Factor Ⅷ Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. China Human Coagulation Factor Ⅷ Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Japan Human Coagulation Factor Ⅷ Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Korea Human Coagulation Factor Ⅷ Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. India Human Coagulation Factor Ⅷ Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Southeast Asia Human Coagulation Factor Ⅷ Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Australia Human Coagulation Factor Ⅷ Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Brazil Human Coagulation Factor Ⅷ Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Egypt Human Coagulation Factor Ⅷ Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Saudi Arabia Human Coagulation Factor Ⅷ Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. South Africa Human Coagulation Factor Ⅷ Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Turkey Human Coagulation Factor Ⅷ Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Global Human Coagulation Factor Ⅷ Sales (2016-2026) & (K Units)
Figure 30. Global Human Coagulation Factor Ⅷ Production Capacity (2016-2026) & (K Units)
Figure 31. Global Human Coagulation Factor Ⅷ Production Capacity by Geographic Region: 2020 VS 2021
Figure 32. Human Coagulation Factor Ⅷ Market Drivers
Figure 33. Human Coagulation Factor Ⅷ Market Restraints
Figure 34. Human Coagulation Factor Ⅷ Market Trends
Figure 35. Global Human Coagulation Factor Ⅷ Sales Market Share by Manufacturer in 2020
Figure 36. Global Human Coagulation Factor Ⅷ Revenue Market Share by Manufacturer in 2020
Figure 37. Human Coagulation Factor Ⅷ Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 38. Top 3 Human Coagulation Factor Ⅷ Manufacturer (Revenue) Market Share in 2020
Figure 39. Top 6 Human Coagulation Factor Ⅷ Manufacturer (Revenue) Market Share in 2020
Figure 40. Global Human Coagulation Factor Ⅷ Sales Market Share by Region (2016-2026)
Figure 41. Global Human Coagulation Factor Ⅷ Revenue Market Share by Region (2016-2026)
Figure 42. North America Human Coagulation Factor Ⅷ Revenue (2016-2026) & (USD Million)
Figure 43. Europe Human Coagulation Factor Ⅷ Revenue (2016-2026) & (USD Million)
Figure 44. Asia-Pacific Human Coagulation Factor Ⅷ Revenue (2016-2026) & (USD Million)
Figure 45. South America Human Coagulation Factor Ⅷ Revenue (2016-2026) & (USD Million)
Figure 46. Middle East & Africa Human Coagulation Factor Ⅷ Revenue (2016-2026) & (USD Million)
Figure 47. Global Human Coagulation Factor Ⅷ Sales Market Share by Type (2016-2026)
Figure 48. Global Human Coagulation Factor Ⅷ Revenue Market Share by Type (2016-2026)
Figure 49. Global Human Coagulation Factor Ⅷ Price by Type (2016-2026) & (US$/Unit)
Figure 50. Global Human Coagulation Factor Ⅷ Sales Market Share by Application (2016-2026)
Figure 51. Global Human Coagulation Factor Ⅷ Revenue Market Share by Application (2016-2026)
Figure 52. Global Human Coagulation Factor Ⅷ Price by Application (2016-2026) & (US$/Unit)
Figure 53. North America Human Coagulation Factor Ⅷ Sales Market Share by Country (2016-2026)
Figure 54. North America Human Coagulation Factor Ⅷ Revenue Market Share by Country (2016-2026)
Figure 55. North America Human Coagulation Factor Ⅷ Sales Market Share by Type (2016-2026)
Figure 56. North America Human Coagulation Factor Ⅷ Sales Market Share by Application (2016-2026)
Figure 57. Europe Human Coagulation Factor Ⅷ Sales Market Share by Country (2016-2026)
Figure 58. Europe Human Coagulation Factor Ⅷ Revenue Market Share by Country (2016-2026)
Figure 59. Europe Human Coagulation Factor Ⅷ Sales Market Share by Type (2016-2026)
Figure 60. Europe Human Coagulation Factor Ⅷ Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Human Coagulation Factor Ⅷ Sales Market Share by Region (2016-2026)
Figure 62. Asia-Pacific Human Coagulation Factor Ⅷ Revenue Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Human Coagulation Factor Ⅷ Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Human Coagulation Factor Ⅷ Sales Market Share by Application (2016-2026)
Figure 65. South America Human Coagulation Factor Ⅷ Sales Market Share by Country (2016-2026)
Figure 66. South America Human Coagulation Factor Ⅷ Revenue Market Share by Country (2016-2026)
Figure 67. South America Human Coagulation Factor Ⅷ Sales Market Share by Type (2016-2026)
Figure 68. South America Human Coagulation Factor Ⅷ Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Human Coagulation Factor Ⅷ Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Human Coagulation Factor Ⅷ Revenue Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Human Coagulation Factor Ⅷ Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Human Coagulation Factor Ⅷ Sales Market Share by Application (2016-2026)
Figure 73. Sales Channel: Direct Channel vs Indirect Channel
Figure 74. Methodology
Figure 75. Research Process and Data Source
世界のヒトFGFR3（線維芽細胞成長因子受容体）市場規模・現状・予測（2021年-2027年） FGFR3, also known as CD333, Is a member of the fibroblast growth factor receptor (FGFR) family, with its amino acid sequence being highly conserved between members and among divergent species. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-leng…- 世界の第VIII因子欠乏症治療市場規模・現状・予測（2021年-2027年） Factor VIII is an essential blood-clotting protein, which is also known as an antihemophilic factor. In individuals, factor VIII is encoded by F8 gene. Defects in F8 gene lead to hemophilia A, a recessive X-linked coagulation disorder. Factor VIII is generated in liver sinusoidal cells and endotheli…
- 世界の血友病A・B組換え因子補充療法市場規模・現状・予測（2021年-2027年） Haemophilia is a group of inherited genetic disorders which causes abnormal or exaggerated bleeding. It impairs the normal mechanism of blood clotting after an injury. Internal bleeding inside the joint or inside brain is commonly seen in the patients with severe to moderate haemophilia. Its symptom…
- 世界の第VIII因子欠乏症治療市場 2021：企業別、地域別、種類・用途別 The Factor VIII Deficiency Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- 世界の抗血友病因子（組換え）市場規模・現状・予測（2021年-2027年） Antihemophilic factor is a naturally occurring protein in the blood that helps blood to clot. Market Analysis and Insights: Global Antihemophilic Factor (Recombinant) Market The global Antihemophilic Factor (Recombinant) market size is projected to reach US$ XX million by 2027, from US$ XX million i…